These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 24474270)
41. Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration. Ozawa Y; Shigeno Y; Nagai N; Suzuki M; Kurihara T; Minami S; Hirano E; Shinoda H; Kobayashi S; Tsubota K BMC Ophthalmol; 2017 Aug; 17(1):161. PubMed ID: 28851319 [TBL] [Abstract][Full Text] [Related]
43. Macular pigment: quantitative analysis on autofluorescence images. Trieschmann M; Spital G; Lommatzsch A; van Kuijk E; Fitzke F; Bird AC; Pauleikhoff D Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1006-12. PubMed ID: 14618343 [TBL] [Abstract][Full Text] [Related]
44. REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING. You QS; Bartsch DU; Espina M; Alam M; Camacho N; Mendoza N; Freeman WR Retina; 2016 Jul; 36(7):1381-7. PubMed ID: 26655614 [TBL] [Abstract][Full Text] [Related]
45. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center. Bernstein PS; Ahmed F; Liu A; Allman S; Sheng X; Sharifzadeh M; Ermakov I; Gellermann W Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6178-86. PubMed ID: 22879423 [TBL] [Abstract][Full Text] [Related]
46. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study. Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657 [TBL] [Abstract][Full Text] [Related]
47. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation. Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715 [TBL] [Abstract][Full Text] [Related]
48. Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Sasamoto Y; Gomi F; Sawa M; Sakaguchi H; Tsujikawa M; Nishida K Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):927-32. PubMed ID: 21071730 [TBL] [Abstract][Full Text] [Related]
49. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Helb HM; Charbel Issa P; VAN DER Veen RL; Berendschot TT; Scholl HP; Holz FG Retina; 2008 Jun; 28(6):808-16. PubMed ID: 18536596 [TBL] [Abstract][Full Text] [Related]
50. Macular pigment changes in pseudophakic eyes quantified with resonance Raman spectroscopy. Obana A; Tanito M; Gohto Y; Gellermann W; Okazaki S; Ohira A Ophthalmology; 2011 Sep; 118(9):1852-8. PubMed ID: 21641040 [TBL] [Abstract][Full Text] [Related]
51. Effect of 1-year lutein supplementation on macular pigment optical density and visual function. Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Nishida K Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1847-54. PubMed ID: 21850440 [TBL] [Abstract][Full Text] [Related]
52. Macular pigment in ophthalmic practice; a survey. Murray IJ; Hassanali B; Carden D Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2355-62. PubMed ID: 23912797 [TBL] [Abstract][Full Text] [Related]
53. The association between dark adaptation and macular pigment optical density in healthy subjects. Patryas L; Parry NR; Carden D; Aslam T; Murray IJ Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):657-63. PubMed ID: 24413682 [TBL] [Abstract][Full Text] [Related]
54. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901 [TBL] [Abstract][Full Text] [Related]
55. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative. LaRowe TL; Mares JA; Snodderly DM; Klein ML; Wooten BR; Chappell R; Ophthalmology; 2008 May; 115(5):876-883.e1. PubMed ID: 17868874 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of Macular Pigment Optical Density in Healthy Eyes Based on Dual-Wavelength Autofluorescence Imaging in South Indian Population. Srinivasan R; Teussink MM; Sloan KR; Surya J; Raman R Transl Vis Sci Technol; 2020 Jul; 9(8):40. PubMed ID: 32855886 [TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein E genotype is associated with macular pigment optical density. Loane E; McKay GJ; Nolan JM; Beatty S Invest Ophthalmol Vis Sci; 2010 May; 51(5):2636-43. PubMed ID: 20107178 [TBL] [Abstract][Full Text] [Related]
58. Macular and Plasma Xanthophylls Are Higher in Age-related Macular Degeneration than in Normal Aging: Alabama Study on Early Age-related Macular Degeneration 2 Baseline. McGwin G; Kar D; Berlin A; Clark ME; Swain TA; Crosson JN; Sloan KR; Owsley C; Curcio CA Ophthalmol Sci; 2023 Jun; 3(2):100263. PubMed ID: 36864830 [TBL] [Abstract][Full Text] [Related]
59. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793 [TBL] [Abstract][Full Text] [Related]
60. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis. Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]